Fraunhofer

by Prof Dr med. habil. E. W. J. Mikus

In 2011, as part of an in vitro study at the Fraunhofer Institute, over 7,000 cell samples were analysed, which were treated with different frequency spectra of Bioresonance according to Paul Schmidt and the RAH as well as with different bioresonance devices. The treated cell samples were compared with non-treated cell samples. The study conclusively demonstrated that bioresonance devices, with their harmonising oscillations, can increase the metabolic activity of fibroblasts by up to 8 %. The study also provided interesting results on the repair of keratinocytes: Damaged cells show significantly higher activity in the cell division phase. For example, with the Rayocomp PS 1000, there is an increase of over 40 %.

Note: In vitro studies cannot be transferred 1:1 to humans.

Final Report

The Fraunhofer Institute comes to the following conclusions in its final report (p.20):